Searchable abstracts of presentations at key conferences in endocrinology
ea0026p584 | Clinical case reports | ECE2011
Tolvaptan versus conventional treatment in hyponatraemia secondary to syndrome of inappropriate anti-diuretic hormone (SIADH): first case experience in West-Midlands region, UK
Introduction: Tolvaptan is an oral vasopressin V2 receptor antagonist which offers a targeted approach in regulating body water and serum [Na+] and is a novel treatment for hyponatraemia secondary to SIADH. Here we report our first case experience with tolvaptan comparing its efficacy with conventional treatments in the same patient.Case report: A 52-year-old lady was admitted with confusion, nausea and vomiting. She gave a 3-month ...
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more